Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism." Cochrane Abstracts, Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/repview. Accessed 30 April 2024.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. Cochrane Abstracts. https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/repview. Accessed April 30, 2024.
Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism. In Cochrane Abstracts https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/repview
Fixed Dose Subcutaneous Low Molecular Weight Heparins Versus Adjusted Dose Unfractionated Heparin for the Initial Treatment of Venous Thromboembolism [Internet]. In: Cochrane Abstracts. [cited 2024 April 30]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/repview.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Fixed dose subcutaneous low molecular weight heparins versus adjusted dose unfractionated heparin for the initial treatment of venous thromboembolism
ID - 431752
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/431752/2/repview
DB - Evidence Central
DP - Unbound Medicine
ER -